secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001193125-23-145153
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$2.96M via private placement of 7.9M shares at $0.37428
------------------------------------------------------------------------

- Sold 7,908,516 shares at $0.37428/share for $2.96M gross proceeds; closed May 15, 2023.
- Proceeds to fund pepinemab development in cancer/neurodegenerative disease and working capital.
- FCMI Parent Co., controlled by chairman Albert D. Friedberg, participated in the offering.
- Shares unregistered; exempt under Rule 506 and Section 4(a)(2); registration rights granted to other investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523145153/0001193125-23-145153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523145153/d464446d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-145153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer